Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 9.8B | 9.1B | 9.3B | 8.6B |
Cost of revenue | 6.8B | 4.0B | 6.0B | 4.1B |
Gross profit | 3.0B | 5.1B | 3.3B | 4.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.4B | 1.6B | 1.5B | 1.4B |
Operating income | -484M | 1.5B | 2M | 1.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 156M | 190M | 105M | 175M |
Other income expense | — | — | — | — |
Pretax income | -610M | 1.2B | 53M | 2.6B |
Tax provision | -415M | -572M | -115M | 473M |
Net income | -195M | 1.8B | 168M | 2.2B |
Basic EPS | 0.1 | 4.8 | 1.3 | 5.5 |
Diluted EPS | 0.1 | 4.8 | 1.3 | 5.5 |
Basic average shares | 201.8M | 203.3M | 203.8M | 201.1M |
Diluted average shares | 201.8M | 203.3M | 203.8M | 201.1M |
EBITDA | 91M | 2.0B | 659M | 2.1B |
Net income from continuing op. | -610M | 1.3B | 53M | 2.6B |
Minority interests | 207M | -834M | 97M | -1.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |